:


Bensimon G et al: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 330:585, 1994

Brooks BP, Fischbeck KH: Spinal and bulbar muscular atrophy: A trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci 18:459, 1995

Crawford TO: From enigmatic to problematic: The new molecular genetics of childhood spinal muscular atrophy. Neurology 46:335, 1996

Dalakas MC: The post-polio syndrome as an evolved clinical entity. Definition and clinical description. Ann N Y Acad Sci 753:68, 1995

Ikeda M et al: Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neurology 45:2038, 1995

Kunst CB et al: Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 15:91, 1997

Lacomblez L et al: Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347:1425, 1996

La Spada AR et al: Androgen receptor gene mutations in X-linked spinal muscular atrophy. Nature 352:77, 1991

Martin JB: CNS genetic disorders: Loss of function, gain of function, or something else? Curr Opin Neurobiol 5:669, 1995

Navon R et al: A new mutation in the HEXA gene associated with a spinal muscular atrophy phenotype. Neurology 45:539, 1995

Parano E et al: Molecular basis of phenotypic heterogeneity in 2siblings with spinal muscular atrophy. Ann Neurol 40:247, 1996

Rosen DR et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59, 1993

Smith RA (ed.): Handbook of Amyotrophic Lateral Sclerosis. New York, Marcel Dekker, 1992

Vechio JD: Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis. Ann Neurol 40:603, 1996

:

  • ()